newsfilter
← Latest News
GlobeNewswire·

Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit

WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (NASDAQ:PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the